Europe Medicinal Chemistry for Drug Discovery Market, By Process (Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization and Candidate Validation), Design (Fragment-Based Variation, Structure-Based Drug Design, Diversity Oriented Synthesis, Chemogenomics, Natural Products and Others), Drug Type (Small Molecules and Biologics), Therapeutic Area (Oncology, Neurology, Infectious and Immune System Diseases, Cardiovascular Diseases, Digestive System Diseases and Others), End User (Contract Research Organization, Pharmaceuticals and Biotechnology Companies, Academic and Research Institutes and Others), Country (Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Belgium, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe) Industry Trends and Forecast to 2029
Get Exclusive Sample Copy of this Report Here
Market Analysis and Insights: Europe Medicinal Chemistry for Drug Discovery Market
Europe medicinal chemistry for drug discovery market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 13.7% in the forecast period of 2022 to 2029 and is expected to reach USD 3,890.66 million by 2029. Increase in research and development investment for discovery and development of novel drug molecules and rise in chronic diseases are the major drivers which propelled the demand of the market in the forecast period.
Medicinal chemistry for drug discovery comprises features such increasing need for safe and effective drugs will impact in launching new product by the manufactures into the market which enhance its demand as well as increase in research and development investment for discovery and development of novel drug molecules leads to the market growth. Currently various research studies are taking place which is expected to provide various other opportunities in the medicinal chemistry for drug discovery market. However, rise in cost of the formulated drug and lack of trained skilled professionals expected to restraint the market growth in the forecast period.
The medicinal chemistry for drug discovery market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.
Get Exclusive Sample Copy of this Report Here
Medicinal Chemistry for Drug Discovery Market Scope and Market Size
Medicinal chemistry for drug discovery market is segmented on the based on the basis of process, design, drug type, therapeutic area, end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of process, the Europe medicinal chemistry for drug discovery market is segmented into target selection, target validation, hit-to-lead identification, lead optimization, and candidate validation. In 2022, target selection segment is expected to dominate the market owing to the fact that is the first process performed for medicinal chemistry for drug discovery and approximately every drug molecule passes through this process before entering the next process.
- On the basis of design, the Europe medicinal chemistry for drug discovery market is segmented into fragment-based variation, structure-based drug design, diversity oriented synthesis, chemogenomics, natural products and others. In 2022, the fragment based variation segment is expected to dominate the market as this design provides with highly accurate results and majorly used for discovery of small molecule drugs.
- On the basis of drug type, the Europe medicinal chemistry for drug discovery market is segmented into small molecules and biologics. In 2022, small molecules segment is expected to dominate the market as most of the drug going under drug discovery are small molecules as compared to that of the biologic drug molecules.
- On the basis of therapeutic area, the Europe medicinal chemistry for drug discovery market is segmented into oncology, infectious and immune system disease, neurology, cardiovascular disease, digestive system disease and others. In 2022, oncology segment is expected to dominate the market due to increasing prevalence of different cancer types and rising demand of advanced, safe and effective therapeutic molecules.
- On the basis of end user, the Europe medicinal chemistry for drug discovery market is segmented into contract research organization, academic and research institutes, pharmaceutical & biotechnology companies and others. In 2022, contract research organization is expected to dominate in the market as these organizations are highly focused on drug discovery and most of the pharmaceuticals, biotechnology companies among others work in collaboration with contract research organization for accelerated drug discovery.
Get Exclusive Sample Copy of this Report Here
Medicinal Chemistry for Drug Discovery Market Country Level Analysis
The medicinal chemistry for drug discovery market is analyzed and market size information is provided on the basis of process, design, drug type, therapeutic area and end user.
The countries covered in the medicinal chemistry for drug discovery market report are the Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Belgium, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, rest of Europe.
Germany is leading the growth of the Europe medicinal chemistry for drug discovery market and target selection segment is dominating in this country due to increase in collaboration among researchers and pharmaceutical industries. France is expected to grow due to the increasing research facility institutes in France and growing pharmaceutical expenditure. U.K. is expected to grow due to growing technological advancement for drug development.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Rise in healthcare expenditure and rising funding for research and development are boosting the market growth of medicinal chemistry for drug discovery
Medicinal chemistry for drug discovery market also provides you with detailed market analysis for every country growth in medicinal chemistry for drug discovery industry with medicinal chemistry for drug discovery sales, impact of advancement in the medicinal chemistry for drug discovery technology and changes in regulatory scenarios with their support for the medicinal chemistry for drug discovery market. The data is available for historic period 2011 to 2020.
Competitive Landscape and Medicinal Chemistry for Drug Discovery Market Share Analysis
Medicinal chemistry for drug discovery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to medicinal chemistry for drug discovery market.
Some major companies which are dealing in the medicinal chemistry for drug discovery market are Eurofins Scientific, Covance Inc. (now part of the LabCorp Group), WuXi Apptec, Charles River, Thermo Fisher Scientific, Inc., Pfizer, Inc., Certara, USA, Malvern Panalytical Ltd (Parent Company Spectris PLC), Genscript Biotech Corporation, Aurigene Pharmaceutical Services Ltd. (a subsidiary of Dr. Reddy’s Laboratories Ltd.), and Selvita, among others.
Various market players provides with the latest technologies of medicinal chemistry for drug discovery which are also accelerating the medicinal chemistry for drug discovery market.
For instance,
- In May 2021, Charles River signed a definitive agreement for acquisition of Vigene Biosciences, Inc., a premier, U.S.-based gene therapy contract development and manufacturing organization (CDMO). The company is engaged in providing viral vector-based gene delivery solutions for enhancing the drug discovery process. This initiative has strengthened the company’s footprint in medicinal chemistry for drug discovery market
- In August 2020, Malvern analytical launched Amplify Analytics which allowed pharmaceutical companies to rapidly identify those drug candidates that meet bio-availability and also accelerated the drug development process. This initiative has boosted the company’s growth in medicinal chemistry for drug discovery market
Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market player is enhancing the company market in the medicinal chemistry for drug discovery which also provides the benefit for organization to improve their offering for Bronchiectasis.
SKU-